Pharmaceutical Products Tenders and Contracts in Scotland
550 matching notices from public sector buyers in Scotland, 0 published in the last 30 days.
Recent buyers include NHS National Services Scotland.
550 results
- Awarded contractPublished 19 December 2025
NP49425 Generic and Biosimilar Transition Medicines
£64,103,740
- Awarded contractPublished 24 November 2025
Branded and Biosimilar Ophthalmology
20,671,084
- Closed tenderPublished 21 August 2025
NP49425 Generic and Biosimilar Transition Medicines
£234,969,011
- Awarded contractPublished 18 August 2025
NP30925 Psychiatry and Neurology Medicines
£7,031,939
- Closed tenderPublished 6 August 2025
Branded and Biosimilar Ophthalmology
£146,579,216
- Closed tenderPublished 6 August 2025
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines
£52,999,636
- Stale Pre-tenderPublished 5 August 2025
NP49425 Generic and Biosimilar Transition Medicines
£131,244,104
- Stale Pre-tenderPublished 5 August 2025
NP49425 Generic and Biosimilar Transition Medicines
£131,244,104
- Closed tenderPublished 30 July 2025
NP38625 Compounded Aseptic Medicines
£21,944,507
- Closed tenderPublished 30 July 2025
NP38625 Compounded Aseptic Medicines
£21,944,507
- Awarded contractPublished 25 June 2025
Plasmapheresis Collection Systems
£118,000
- Awarded contractPublished 2 June 2025
Plasmapheresis Collection Systems
£390,000
- Awarded contractPublished 6 May 2025
NP35925 Cardiovascular & Respiratory Medicines
£82,305,880
- Closed tenderPublished 23 April 2025
NP30925 Psychiatry and Neurology Medicines
£41,686,538
- Closed tenderPublished 23 April 2025
NP30925 Psychiatry and Neurology Medicines
£41,686,538
- Awarded contractPublished 14 April 2025
NP34925g Anti-human T lymphocyte immunoglobulin (equine)
£1,398,600
- Awarded contractPublished 14 April 2025
NP34925b Tetanus immunoglobulin intramuscular use (IM)
£753,136
- Awarded contractPublished 14 April 2025
NP34925c Anti Rabies immunoglobulin intramuscular use (IM)
£544,320
- Awarded contractPublished 14 April 2025
NP34925a Hepatitis B immunoglobulin intramuscular use (IM)
£549,120
- Awarded contractPublished 27 February 2025
NP39724 Generic and Biosimilar Cancer Medicines
£10,396,962
Win more Pharmaceutical Products contracts in Scotland with Stotles
Get Pharmaceutical Products alerts, buyer intelligence and bid tools, all in one place.